Advertisement
Abstract

Synthesis of putative metabolites and investigation of the metabolic fate of gliclazide, [1-(3-azabicyclo(3,3,0)oct-3-yl)-3-(4-methylphenylsulfonyl) urea], in diabetic patients.

A R Taylor, R D Brownsill, H Grandon, F Lefoulon, A Petit, W Luijten, P G Kopelman and B Walther
Drug Metabolism and Disposition January 1996, 24 (1) 55-64;

Article Information

vol. 24 no. 1 55-64
PubMed 
8825191
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Published online January 1, 1996.

Author Information

  1. A R Taylor,
  2. R D Brownsill,
  3. H Grandon,
  4. F Lefoulon,
  5. A Petit,
  6. W Luijten,
  7. P G Kopelman and
  8. B Walther
  1. Servier Research and Development Ltd., Fulmer, Slough, UK.

    Statistics from Altmetric.com

    Article usage

    Article usage: August 2017 to August 2022

    AbstractFullPdf
    Aug 20173601
    Sep 2017600
    Oct 20171401
    Nov 20171501
    Dec 20175002
    Jan 20182101
    Feb 20185101
    Mar 20184403
    Apr 2018801
    May 20181500
    Jun 20183004
    Jul 2018600
    Aug 2018500
    Sep 20182801
    Oct 2018400
    Nov 2018300
    Dec 2018200
    Jan 2019200
    Feb 20191200
    Mar 20191701
    Apr 2019901
    May 20191602
    Jun 20191002
    Jul 20191100
    Aug 20191300
    Oct 20191700
    Nov 20192100
    Dec 20191300
    Jan 20201500
    Feb 20201400
    Mar 2020500
    May 20201800
    Jun 2020801
    Jul 20201202
    Aug 2020200
    Sep 2020301
    Oct 20201901
    Nov 2020201
    Dec 20202403
    Jan 20212500
    Feb 20212106
    Mar 20211403
    Apr 2021700
    May 2021700
    Jun 2021800
    Jul 20211201
    Aug 20211102
    Sep 20211002
    Oct 20215301
    Nov 20211900
    Dec 20211701
    Jan 2022100
    Feb 2022301
    Mar 20222604
    Apr 2022901
    May 20221602
    Jun 20221101
    Jul 20222102
    Aug 2022301

    Back to top

    In this issue

    Download PDF
    Article Alerts
    Email Article
    Citation Tools

    Abstract

    Synthesis of putative metabolites and investigation of the metabolic fate of gliclazide, [1-(3-azabicyclo(3,3,0)oct-3-yl)-3-(4-methylphenylsulfonyl) urea], in diabetic patients.

    A R Taylor, R D Brownsill, H Grandon, F Lefoulon, A Petit, W Luijten, P G Kopelman and B Walther
    Drug Metabolism and Disposition January 1, 1996, 24 (1) 55-64;
    del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo

    Jump to section

    Related Articles

    Cited By...

    Similar Articles

    Advertisement